Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Current Deferred Revenue (2022 - 2025)

Crinetics Pharmaceuticals has reported Current Deferred Revenue over the past 4 years, most recently at $1.2 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $1.2 million for Q4 2025, down 43.24% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (down 43.24% YoY), and the annual figure for FY2025 was $1.2 million, down 43.24%.
  • Current Deferred Revenue for Q4 2025 was $1.2 million at Crinetics Pharmaceuticals, down from $1.6 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CRNX hit a ceiling of $9.4 million in Q2 2022 and a floor of $1.2 million in Q4 2025.
  • Median Current Deferred Revenue over the past 4 years was $2.6 million (2022), compared with a mean of $4.6 million.
  • Peak annual rise in Current Deferred Revenue hit 185.88% in 2023, while the deepest fall reached 75.35% in 2023.
  • Crinetics Pharmaceuticals' Current Deferred Revenue stood at $8.3 million in 2022, then plummeted by 75.35% to $2.1 million in 2023, then increased by 5.84% to $2.2 million in 2024, then plummeted by 43.24% to $1.2 million in 2025.
  • The last three reported values for Current Deferred Revenue were $1.2 million (Q4 2025), $1.6 million (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.